









Markets
/
Stocks
/
nasdaq-dcoy
/

Salarius Pharmaceuticals Ord Shs

DCOY

0.820USD

+0.050+6.47%

Close 01/09, 16:00（ET）Quotes delayed by 15 min

--Market Cap

--P/E TTM



Salarius Pharmaceuticals Ord Shs

0.820

+0.050+6.47%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Salarius Pharmaceuticals Ord Shs to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

---1.65M

Net income from continuing operations

---873.47K

Operating gains losses

--1.11K

Change in working capital

---797.17K

-Change in prepaid expenses

---490.56K

Cash from non-recurring investing activities

Cash from operating activities

---1.65M

Investing cash flow

Net cash flow from other investing activities

---200.00K

Cash from non-current investing activities

Net cash flow from investing activities

---200.00K

Financing cash flow

Cash flow from continuous financing activities

--5.86M

Net cash flow from debt Issuance/repayment

--0.00

Net cash flow from common stock issuance/repurchase

--5.86M

Net cash from non-recurrent financing activities

Net cash from financing activities

--5.86M

Net cash flow

Beginning cash balance

--794.89K

Current period cash flow changes

--4.01M

Ending cash balance

--4.81M

Free cash flow

---1.65M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

